Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-25-329010

Chief Executive Officer gave 30,000 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2025-12-18 Gift −30,000 224,201 D: show line 1 in the form
Loading xslF345X05/ownership.xml…